3-(4-(4-chlorophenyl-4-hydroxypiperidino)methyl)indole,
L 741,626,
L 741626,
L-741,626,
L-741626,
L-741,626,
81226-60-0,
L-741626,
L 741626,
3-(4-(4-Chlorophenyl-4-hydroxypiperidino)methyl)indole,
L 741,626,
CHEMBL445102,
4-(4-Chlorophenyl)-1-(1H-indol-3-ylmethyl)-4-piperidinol,
4-(4-chlorophenyl)-1-(1h-indol-3-ylmethyl)piperidin-4-ol,
C20H21ClN2O,
4-Piperidinol, 4-(4-chlorophenyl)-1-(1H-indol-3-ylmethyl)-,
SR-01000075973,
NCGC00015591-01,
Tocris-1003,
Lopac-L-135,
Biomol-NT_000036,
AC1Q3NO6,
Lopac0_000742,
GTPL177,
MLS000860079,
AC1L335F,
BPBio1_001094,
ZINC6788,
SCHEMBL11253588,
CHEBI:92090,
CTK3I9542,
DTXSID30230974,
HMS2230F17,
HMS3262E06,
HMS3267M15,
HMS3370K05,
KUC112479N,
Tox21_500742,
BDBM50050467,
MFCD00953632,
PDSP1_001415,
PDSP1_001848,
PDSP2_001399,
PDSP2_001833,
AKOS024456330,
CCG-204827,
LP00742,
NCGC00015591-02,
NCGC00015591-03,
NCGC00015591-04,
NCGC00015591-05,
NCGC00015591-06,
NCGC00015591-07,
NCGC00024932-01,
NCGC00024932-02,
NCGC00024932-03,
NCGC00024932-04,
NCGC00261427-01,
KSC-315-034-,
SMR000326937,
LS-116920,
B6544,
EU-0100742,
L-135,
A13694,
A19235,
L000887,
L741626,
L-741,626, >=98% (HPLC),
L741,626,
SR-01000075973-1,
SR-01000075973-3,
BRD-K05181463-001-01-6,
BRD-K05181463-001-04-0,
3-[4-(4-chlorophenyl)-4-hydroxypiperidinyl]methylindole,
1-((1H-indol-3-yl)methyl)-4-(4-chlorophenyl)piperidin-4-ol,
4-(4-Chloro-phenyl)-1-(1H-indol-3-ylmethyl)-piperidin-4-ol,
(+/-)-3-[4-(4-Chlorophenyl)-4-hydroxypiperidinyl]methylindole,
3-[[4-(4-Chlorophenyl)-4-hydroxypiperidin-l-yl]methyl-1H-indole,
4-(4-CHLOROPHENYL)-1-(1H-INDOL-3-YL METHYL)PIPERIDIN-4-OL,
( inverted exclamation markA)-3-[4-(4-Chlorophenyl)-4-hydroxypiperidinyl]methylindole,
( inverted question mark)-3-[4-(4-Chlorophenyl)-4-hydroxypiperidinyl]methylindole,
D0M3PV,
C20-H21-Cl-N2-O,
LLBLNMUONVVVPG-UHFFFAOYSA-N,
AR-1F6239,
CID133633,
C104750,
5-Chloro-6-(trifluoromethyl)-2,4(1H,3H)-Pyrimidinedione,
5-chloro-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione,
85730-40-1,